Why Five Below (FIVE) Stock Is Trading Up Today

Five Below (FIVE) shares rose 6.1% after Mizuho and other analysts raised price targets following strong Q2 results. Revenue was $1.26B (+22.9% YoY), EPS $1.68 (+19.3% vs. estimates). The company raised FY guidance and expanded to 2,022 stores. (280/350 chars)

Original reporting
Published Sep 4, 2026, 5:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 4, 2026, 6:37 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Why Five Below (FIVE) Stock Is Trading Up Today — source image
Decision brief

The 30-second read

$FIVEBullishMed
01

Why it matters

The earnings beat and guidance lift provide a fresh catalyst for price appreciation.

02

Market read

Strong earnings and analyst upgrades drive a notable intraday rally, indicating short-term buying interest.

03

What to watch

Potential supply chain constraints or consumer spending slowdown could temper growth.

Relevance 8/10Novelty 8/10Timing: today

Background

Five Below reported Q2 results beating estimates and raised its full-year outlook, prompting analyst target upgrades.

Company-level read

Ticker impact

$FIVEBullishHigh confidence
Context

Shares jumped 6.1% after analysts raised price targets and the company reported Q2 earnings beat and raised full-year guidance.

Expected impact

Potential continued rally toward $280-$300 range.

Evidence & confidence

Strong revenue growth, EPS beat, and multiple analyst target hikes create clear bullish catalyst.

Market effects

Discount retail sector may see broader optimism as Five Below outperforms expectations.

U.S. retail stocks could benefit from the earnings beat.

Limited to U.S. equity markets.

Counterpoint

The stock may be overbought after a sharp intraday move; caution on valuation.

Key entities

  • Five Below

    Discount retailer reporting Q2 earnings.

  • Mizuho Securities

    Raised price target to $295.

Related articles

$FIVEHighAI 8/10

Five Below Shares Rise After Q2 Earnings Beat and Guidance Increase

Five Below (FIVE) shares rose 6.2% premarket after Q2 earnings beat estimates ($1.68 EPS vs. $1.33) and net sales grew 22.9% YoY to $1.26B. Comparable sales increased 14.1%. The company raised FY2026 guidance for net sales ($5.63B-$5.71B) and EPS ($9.83-$10.31). Analysts updated price targets (DB: $334, JEF: $350).

$FIVEMedAI 8/10

Five Below Q2 Earnings Call Highlights

Five Below (FIVE) opened 52 net new stores in Q2, ending with 2,022 locations. Adjusted gross profit rose 31% to $449M, and adjusted operating income more than doubled to $113M. The company raised its full-year sales outlook to $5.63B-$5.71B and expects Q3 sales of $1.21B-$1.23B. It plans to invest in store experience and digital capabilities using tariff refunds.

$FIVEHighAI 8/10

Cramer says buy this retail stock after the market got its latest quarter all wrong

Jim Cramer of CNBC's 'Mad Money' argued that Five Below's stock is undervalued after its latest quarterly results, despite a market downturn. The retailer beat expectations with 14.1% comparable sales growth and raised its full-year guidance. Cramer attributed the market's reaction to concerns about decelerating growth and higher oil prices, but he highlighted CEO Winnie Park's successful turnaround strategy. Five Below's new earnings forecast implies over 50% growth, making the stock attractive

$SNOWMed

Stocks making the biggest moves premarket: Snowflake, Moderna, Broadcom & more

Snowflake shares surged 24% after Q2 results beat estimates, with revenue of $1.55B and EPS of $0.62. Broadcom fell 2.5% on lower Q4 revenue forecasts. Campbell's dropped 7% on weak fiscal 2027 guidance. Ultragenyx plunged 46% after a failed drug trial. Petco rose 9% on strong Q2 margins. Moderna declined 2% after a downgrade. Argan gained 7.5% on better-than-expected earnings. Five Below rose 4.5% on strong Q2 results. Victoria's Secret fell 18% on missed revenue estimates. Netskope rose 12% on